RxDoctor Payments Data

Alicia Fridgen, PA

Medical · Warrenton, VANPI 1790086510

Payments from drug & device makers

$2,186in general payments, 2019–2025

Across 133 payments — averaging $16.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$432
  • Pfizer$252
  • AbbVie$243
  • Lilly USA, LLC$214
  • Amgen$151
  • Boehringer Ingelheim$91
  • plus $803 from 26 others

What the payments were for

  • Food & beverage$2,17499%
  • Education$121%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,186 in reported general payments places this provider in the 75th percentile of 632 medical providers in Virginia.

See all medical providers in Virginia

Medicare billing

Part B allowed, 2024
$36,605
Medicare patients
166
Services billed
877

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab14$93,932
OzempicSemaglutide49$69,243
JardianceEmpagliflozin28$40,014
TrulicityDulaglutide16$20,179
FarxigaDapagliflozin Propanediol13$18,591
Trelegy ElliptaFluticasone/Umeclidin/Vilanter18$15,445
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$12,607
Tresiba Flextouch U-200Insulin Degludec19$10,066
Spiriva RespimatTiotropium Bromide11$5,669
Tresiba Flextouch U-100Insulin Degludec11$5,454
Fiasp PenfillInsulin Aspart (Niacinamide)11$4,464
SymbicortBudesonide/Formoterol Fumarate11$4,246
Memantine Hcl12$3,123
Levothyroxine Sodium176$2,596
Ezetimibe-SimvastatinEzetimibe/Simvastatin12$2,213

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$432$69,24349 claims
Boehringer IngelheimJardiance, Spiriva Respimat$91$45,68239 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$68$35,44536 claims
Lilly USA, LLCTrulicity$214$20,17916 claims
GSKTrelegy Ellipta$47$15,44518 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$13$2,596176 claims
AbbVieSynthroid$243$1,14521 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 632 medical providers in Virginia.

Other medical in Warrenton

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →